发明名称 DRY POWDER COMPOSITIONS HAVING IMPROVED DISPERSIVITY
摘要 The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject.
申请公布号 WO0132144(A1) 申请公布日期 2001.05.10
申请号 WO2000US09785 申请日期 2000.04.12
申请人 INHALE THERAPEUTIC SYSTEMS, INC.;LECHUGA-BALLESTEROS, DAVID;KUO, MEI-CHANG 发明人 LECHUGA-BALLESTEROS, DAVID;KUO, MEI-CHANG
分类号 A61K47/42;A61K9/00;A61K9/08;A61K9/12;A61K9/14;A61K9/72;A61K31/58;A61K38/00;A61K38/21;A61K38/22;A61K38/23;A61K38/27;A61K38/28;A61K38/43;A61K38/55;A61K39/395;A61K45/00;A61K47/12;A61K47/16;A61K47/18;A61K47/26;A61K47/30;A61P1/04;A61P1/08;A61P3/02;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P5/28;A61P7/02;A61P7/12;A61P9/00;A61P9/06;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P15/18;A61P19/02;A61P21/00;A61P25/02;A61P25/06;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/26;A61P29/00;A61P31/00;A61P31/04;A61P31/10;A61P31/12;A61P33/06;A61P33/10;A61P35/00;A61P37/00;A61P39/06;(IPC1-7):A61K9/12 主分类号 A61K47/42
代理机构 代理人
主权项
地址